Literature DB >> 9126553

What happens inside lentivirus or influenza virus infected cells: insights into regulation of cellular and viral protein synthesis.

M Gale1, M G Katze.   

Abstract

Efficient manipulation of the regulatory mechanisms controlling host cell gene expression provides the means for productive infection by animal viruses. Upon infecting the host cell, viruses must: (i) bypass the cellular antiviral defense mechanisms to prevent the translational blocks imposed by the interferon pathway; and (ii) effectively "hijack" the host protein synthetic machinery into mass production of virion protein components. The multicomponent regulatory nature of cellular gene expression has provided the means of selecting for a diverse range of mechanisms utilized by animal viruses to ensure that replication efficiency is maintained throughout the virus life cycle. One important research component of the careful examination of gene regulation is those studies that focus on elucidating the mechanisms by which viruses control mRNA translation during host cell infection. Much of the work in our laboratory has focused on elucidating the strategies by which human immunodeficiency virus type 1 and influenza virus regulate protein synthesis during infection. Here we describe the ways in which these two distinctly different RNA viruses ensure the selective and efficient translation of their viral mRNAs in infected cells. These strategies include circumvention of the deleterious effects associated with activation of the interferon-induced protein kinase, PKR. Herein we describe our methodologies designed to elucidate the translational regulation in cells infected by these viruses. We conclude with a brief summary of new directions, utilizing these methods, taken toward understanding the translational control mechanisms imposed by these viral systems, and how our studies of virally infected cells have allowed us to identify growth-regulating components of normal, uninfected cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126553     DOI: 10.1006/meth.1996.0436

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  7 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK.

Authors:  M Gale; C M Blakely; D A Hopkins; M W Melville; M Wambach; P R Romano; M G Katze
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

3.  The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.

Authors:  G E Price; A Gaszewska-Mastarlarz; D Moskophidis
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.

Authors:  Jill Pflugheber; Brenda Fredericksen; Rhea Sumpter; Chunfu Wang; Felecia Ware; Donald L Sodora; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

6.  An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.

Authors:  Jinhua Xiang; James H McLinden; Qing Chang; Thomas M Kaufman; Jack T Stapleton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

7.  Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.

Authors:  Chunfu Wang; Jill Pflugheber; Rhea Sumpter; Donald L Sodora; Daniel Hui; Ganes C Sen; Michael Gale
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.